全文获取类型
收费全文 | 1344篇 |
免费 | 106篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 96篇 |
妇产科学 | 17篇 |
基础医学 | 121篇 |
口腔科学 | 32篇 |
临床医学 | 194篇 |
内科学 | 306篇 |
皮肤病学 | 33篇 |
神经病学 | 63篇 |
特种医学 | 272篇 |
外国民族医学 | 1篇 |
外科学 | 111篇 |
综合类 | 22篇 |
预防医学 | 59篇 |
眼科学 | 15篇 |
药学 | 53篇 |
中国医学 | 6篇 |
肿瘤学 | 53篇 |
出版年
2024年 | 3篇 |
2023年 | 11篇 |
2022年 | 4篇 |
2021年 | 20篇 |
2020年 | 8篇 |
2019年 | 15篇 |
2018年 | 39篇 |
2017年 | 25篇 |
2016年 | 28篇 |
2015年 | 29篇 |
2014年 | 47篇 |
2013年 | 35篇 |
2012年 | 22篇 |
2011年 | 35篇 |
2010年 | 55篇 |
2009年 | 70篇 |
2008年 | 49篇 |
2007年 | 31篇 |
2006年 | 38篇 |
2005年 | 22篇 |
2004年 | 26篇 |
2003年 | 29篇 |
2002年 | 29篇 |
2001年 | 33篇 |
2000年 | 37篇 |
1999年 | 28篇 |
1998年 | 53篇 |
1997年 | 56篇 |
1996年 | 65篇 |
1995年 | 54篇 |
1994年 | 46篇 |
1993年 | 50篇 |
1992年 | 27篇 |
1991年 | 12篇 |
1990年 | 17篇 |
1989年 | 42篇 |
1988年 | 36篇 |
1987年 | 41篇 |
1986年 | 36篇 |
1985年 | 25篇 |
1984年 | 20篇 |
1983年 | 10篇 |
1982年 | 22篇 |
1981年 | 14篇 |
1980年 | 8篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 13篇 |
排序方式: 共有1459条查询结果,搜索用时 15 毫秒
1.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
2.
5H-Mebendazole and some related heterocyclic methyl carbamates were synthesized and their anthelmintic activity against Caenorhabditis elegans was determined. In order to study the influence of the heteroaromatic region with regard to the carbamate moiety on biological activity, the molecular electrostatic potentials (MEP) of all structures were calculated and a structure-activity relationship (SAR) was established. The electrostatic pattern of activity includes two minima of the carbamate moiety, a third heterocyclic minimum, and a pi-electronic region. 相似文献
3.
4.
5.
6.
7.
8.
M Alvarez R Granados D Mauleón G Rosell M Salas J Sallés N Valls 《Journal of medicinal chemistry》1987,30(7):1186-1193
The synthesis and irreversible alpha-blocking activity in the rat vas deferens of a series of tetra- and diamine disulfides 2-38, structural analogues of benextramine (BHC), are described. All compounds containing a central cystamine moiety displayed an irreversible alpha-adrenergic blockade at concentrations ranging from 10(-4) to 6 X 10(-6)M. Potency was increased in cystamines N,N'-disubstituted with 6-aminohexyl groups, especially when the outer nitrogen atoms bear arylalkyl substituents or are enclosed in a ring. However, N,N,N',N'-tetrasubstituted cystamines were poor blockers. Structural specificity in the outer portion of the tetramine disulfide is low, since many types of substituents gave rise to potent alpha-blockers. Even replacement of the outer amines with nonbasic ethers or amides was observed to maintain irreversible alpha-blockade. 相似文献
9.
10.